Atlas Trials

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Clinical trial NCT03435146 · COMPLETED

Trial details

NCT number
NCT03435146
Sponsor
The Aurum Institute NPC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Respiratory Tract InfectionsHIV Infections
Start date
2018-01-18
Primary completion
2022-12-07
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.